| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/17/2005 | US20050059895 System and methods for monitoring a patient's heart condition |
| 03/17/2005 | US20050059872 Electrically-conductive patterns for monitoring the filling of medical devices |
| 03/17/2005 | US20050059803 Oligonucleotide probe for use in detection of phosphatidyl inositol 3 kinase expression; fungicides; antitumor agents |
| 03/17/2005 | US20050059801 Transmembrane receptor/chemokine receptor for use in identifying modulators for treatment of glomerulonephritis, asthma, inflammatory bowel, transplant rejection and inflammation |
| 03/17/2005 | US20050059711 Potentiators of insulin secretion |
| 03/17/2005 | US20050059688 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis |
| 03/17/2005 | US20050059630 TTK in diagnosis and as a therapeutic target in cancer |
| 03/17/2005 | US20050059628 Modulation of beta-catenin/TCF-activated transcription |
| 03/17/2005 | US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/17/2005 | US20050059589 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding |
| 03/17/2005 | US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening |
| 03/17/2005 | US20050059581 Endometrial/epithelial cancer; peroxisome proliferator-activated receptor gamma agonists such as pioglitazone and rosiglitazone |
| 03/17/2005 | US20050059580 Biglycan and related therapeutics and methods of use |
| 03/17/2005 | US20050059575 Assays |
| 03/17/2005 | US20050059174 Inspection system and apparatus |
| 03/17/2005 | US20050059169 Solid support comprising reflection-suppressing function and capable of producing high signal intensity from a fluorescent molecule; improved quantification performance |
| 03/17/2005 | US20050059167 Quantum information processing elements and quantum information processing platforms using such elements |
| 03/17/2005 | US20050059163 Multicompartment apparatus comprising stabilizing additive for separating whole blood into component parts; storage stability and transportation; enhanced shelf-life |
| 03/17/2005 | US20050059160 Method and apparatus for quantifying a rapid immunochromatographic test |
| 03/17/2005 | US20050059158 Determining concentration of preferential particles in solution via fluorescent excitation; fluorescent semiconductor elements |
| 03/17/2005 | US20050059157 Apparatus comprising infrared sensor a nd sodium carbonate-coated filter for use in monitoring nitrate concentration in air; pollution control; air quality analysis |
| 03/17/2005 | US20050059156 Detecting presence of organic chemical contaminant in an anthracycline product via chromatographic separation and DNA elution |
| 03/17/2005 | US20050059150 Providing solid support comprising immobilized extracellular matrix protein and cell adhesion resistant (CAR) material for use as tool in propagation and maintenance hepatic tissues; regenerative medicine; tissue engineering and repair |
| 03/17/2005 | US20050059148 Wherein cell stressor is light, retinoid, cigarette smoke condensate, increased hydrostatic pressure, or glutamate; neurodegenerative diseases |
| 03/17/2005 | US20050059140 Methods of surface modification to enhance cell adhesion |
| 03/17/2005 | US20050059139 Device substrate, method of manufacturing the same, and microchip |
| 03/17/2005 | US20050059137 Bio-support and preparing method of the same |
| 03/17/2005 | US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis |
| 03/17/2005 | US20050059118 Hyaluronan receptor for endocytosis |
| 03/17/2005 | US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents |
| 03/17/2005 | US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders |
| 03/17/2005 | US20050059109 Methods and compositions for polypeptide engineering |
| 03/17/2005 | US20050059107 Method of selecting hla-dp4 ligands and the applications thereof |
| 03/17/2005 | US20050059105 Impedimetric biosensor and its use for rapid detection of bacterial pathogens in solution |
| 03/17/2005 | US20050059104 Using tumor marker CA19-9 as tool in detection of infection; immunodiagnostics |
| 03/17/2005 | US20050059103 Detecting immune response signature and mycobacterial infection; immunodiagnostics |
| 03/17/2005 | US20050059102 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/17/2005 | US20050059100 For detecting and analyzing oxidized polypeptides, nucleic acids, lipids, and polysaccharides; kits; neurodegenerative/neoplastic/vascular/autoimmune disorders |
| 03/17/2005 | US20050059099 PSCA: prostate stem cell antigen and uses thereof |
| 03/17/2005 | US20050059097 Quantitative binding assays using green fluorescent protein as a label |
| 03/17/2005 | US20050059096 Using acyl-coa oxidase as tool in identifying modulators for detection, prevention and treatment of liver and cardiovascular disorders |
| 03/17/2005 | US20050059095 Using random encoded array detection (READ) format as diagnostic tool in detection of multiple cell-surface and transmembrane proteins; disease diagnostic and drug screening |
| 03/17/2005 | US20050059094 Electrophysiological assay using oocytes that express human ENaC and the use phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059092 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 03/17/2005 | US20050059091 using a scanning probe microscope to determine and calculate the binding affinity between the first object and the first material from the force applied to remove the object from the first material. |
| 03/17/2005 | US20050059089 Complexes of GPCR142 and relaxin3 or INSL5, and their production and use |
| 03/17/2005 | US20050059087 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/17/2005 | US20050059085 Thermus transcriptional replicative protein for use in identifying modulator which inhibit bacterial growth; rational drug design and screening; bactericides |
| 03/17/2005 | US20050059084 Using presence of preferential helical structure in protein to diagnose/prognose prion and nervous system disorders; treatment and prevention alzheimer's and spongiform encephalopathy |
| 03/17/2005 | US20050059083 High throughput method to identify ligands for cell attachment |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050059072 Selective modulation of TLR gene expression |
| 03/17/2005 | US20050059068 Bonding DNA, polypeptides, polyamines to glass substrate via silanetriol coupling agent; solid phase synthesis |
| 03/17/2005 | US20050059067 Using restriction fragment length polymorphism in tyrosine kinase varian t as diagnostic tool in detection of cell proliferative and inflammatory disorders |
| 03/17/2005 | US20050059063 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds |
| 03/17/2005 | US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening |
| 03/17/2005 | US20050059045 Labraries of optimized cytochrome P450 enzymes and the optimized P450 enzymes |
| 03/17/2005 | US20050059038 Screening mixture and identifying modulators for treatment and prevention of cell proliferative, nervous system, inflammatory and eating disorders |
| 03/17/2005 | US20050059037 Undergoing a change in the fluorescent signal intensity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized |
| 03/17/2005 | US20050059036 interactions with the fluorescent ligand are then detected by means of the changes in the donor's and acceptor's excitation and/or emission energy spectra; ligands are defined as being pharmacologically significant if interaction with target protein is inhibited by the addition of non-fluorescent ligand |
| 03/17/2005 | US20050059031 Microcrystal solid support comprising cationic polymers and immobilized nucleotide sequences for use as construct in transfer of heterologous gene sequences |
| 03/17/2005 | US20050059028 RNAi-based sensors, caged interfering RNAs, and methods of use thereof |
| 03/17/2005 | US20050059026 Using concentration of degraded or soluble matrix protein as diagnostic indicator of degree of apoptosis/necrosis in cell tissue |
| 03/17/2005 | US20050059023 Methods and kits for monitoring resistance to therapeutic agents |
| 03/17/2005 | US20050059020 Quantum information processing elements and quantum information processing platforms using such elements |
| 03/17/2005 | US20050059014 Using multilayered/graded evanescent field sensor platform for monitoring binding activity of biolpolymers; gene expression analysis; pathogen detection |
| 03/17/2005 | US20050059013 Use of biomarkers for detecting ovarian cancer |
| 03/17/2005 | US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 03/17/2005 | US20050059006 Using presence of polymorphism in ciliary neurotrophic factor (CNTF) gene sequences as diagnostic indicator for lloperidone treatment of psychotic disorders |
| 03/17/2005 | US20050058999 Gene involved in apoptosis regulation |
| 03/17/2005 | US20050058994 Epitopes; immunoglobulins; hybridomas; diagnostic kits |
| 03/17/2005 | US20050058993 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058992 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058990 Apparatus which utilizes patch clamp system to monitor ionic mobility through transport or pore forming proteins; drug screening; anti-hypertension drugs; antiepileptic compounds |
| 03/17/2005 | US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy |
| 03/17/2005 | US20050058687 Covalently attached collagen VI for cell attachment and proliferation |
| 03/17/2005 | US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor |
| 03/17/2005 | US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases |
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/17/2005 | US20050058642 Antagonists and agonists of LDCAM and methods of use |
| 03/17/2005 | US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 03/17/2005 | US20050058633 Stem cells that transform to beating cardiomyocytes |
| 03/17/2005 | US20050058627 TTK in diagnosis and as a therapeutic target in cancer |
| 03/17/2005 | US20050058604 Phthalamide-lanthanide complexes for use as luminescent markers |
| 03/17/2005 | US20050058572 Mixture of oxizier and active fuel; atomizing, mixing under pressure; computer control |
| 03/17/2005 | US20050057749 Novel optical architectures for microvolume laser-scanning cytometers |
| 03/17/2005 | US20050057676 System, method, and product for scanning of biological materials |
| 03/17/2005 | US20050057267 Soot detector for engine oil |
| 03/17/2005 | US20050056814 Complex of chelate compound and polymer; overcoating for analyzing electrode |
| 03/17/2005 | US20050056569 Electrowetting electrode device with electromagnetic field for actuation of magnetic-bead biochemical detection system |
| 03/17/2005 | US20050056083 Method for determining engine lubricating oil condition |
| 03/17/2005 | US20050056082 Continuous tracer generation apparatus |
| 03/17/2005 | US20050056079 Continuous blending for gas analyzer calibration |
| 03/17/2005 | DE10339820A1 Use of G-protein coupled receptor, GPR49, peptides, protein and nucleic acid, for diagnosis and prognosis of tumors, also in screening for therapeutic and diagnostic agents |
| 03/17/2005 | DE10339727A1 Verfahren zur Bestimmung der adulten Neurogenese Method for the determination of adult neurogenesis |
| 03/17/2005 | DE10339015A1 Diagnosing a disease, comprises that matter is analyzed in a gas or aerosol phase from the patient's skin by an ion mobility spectrometer, for rapid detection by gas chromatography |
| 03/17/2005 | DE10339014A1 Process and assembly to determine the condition and fitness of food for consumption with ion-mobility spectrometer |
| 03/17/2005 | DE10338430A1 Infrared process to monitor the quality of the mixed dry ingredients in the preparation of noodles, couscous, extruded or agglomerated starch-based food products |
| 03/17/2005 | DE10321809A1 Verfahren zum Drucken von Biomolekülen A method for printing biomolecules |